FDA official logo
GSRS logo
PFDA official logo

CETUXIMAB

  • UNII: PQX0D8J21J
  • Preferred Substance Name: CETUXIMAB

  • 205923-56-4
  • ABP-494
  • C225
  • C-225
  • CETUXIMAB (GENETICAL RECOMBINATION)
  • CETUXIMAB (GENETICAL RECOMBINATION) [JAN]
  • CETUXIMAB [EMA EPAR]
  • CETUXIMAB [HSDB]
  • CETUXIMAB [INN]
  • CETUXIMAB [JAN]
  • CETUXIMAB [MART.]
  • CETUXIMAB [MI]
  • CETUXIMAB [PURPLE BOOK CDER]
  • CETUXIMAB [USAN]
  • CETUXIMAB [VANDF]
  • CETUXIMAB [WHO-DD]
  • CETUXIMAB BIOSIMILAR (ABP-494)
  • CETUXIMAB BIOSIMILAR (SHANGHAI ZHANGJIANG)
  • CMAB009
  • CMAB-009
  • CMAB-009 (BIOSIMILAR OF CETUXIMAB)
  • ERBITUX
  • EXTRACELLULAR DOMAIN HUMAN EGFR BINDING RECOMBINANT, HUMAN/MOUSE CHIMERIC MONOCLONAL ANTIBODY
  • FV REGIONS OF MURINE ANTI-EGFR ANTIBODY WITH HUMAN IGG1 HEAVY AND KAPPA LIGHT CHAIN CONSTANT REGIONS, MW 152000
  • IMC-225
  • IMC-C225
  • IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
  • MOAB C225

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.